Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
08/28/2008 | US20080207615 Using allelic variations in epidermal growth factor gene as evaluative tool in predicting positive response to anticancer agents, therapy; administering gefitinib |
08/28/2008 | US20080207555 Catalyzing the release of ADP-ribose from poly(ADP-ribose) or O-acetyl-ADP-ribose by contacting with an isolated ARH3 polypeptide; modifying DNA repair or chromatin structure by modifying ARH3 polypeptide activity; drug screening; antiinflammatory, antiischemic agents; aging resistance |
08/28/2008 | US20080207552 Decoy compositions for treating and preventing brain diseases and disorders |
08/28/2008 | US20080207550 Immunomodulatory polynucleotides and methods of using the same |
08/28/2008 | US20080207549 An antisense polynucleotide or short interfering RNA; diagnosis of proliferative diseases; targets for drug design; antiproliferative agents |
08/28/2008 | US20080207548 Immunogenic polynucleotides, expression vectors, antigen presenting host cells, diagnostic kits; cancer vaccines |
08/28/2008 | US20080207546 Rna aptamers and methods for identifying the same |
08/28/2008 | US20080207545 Using antisense oligonucleotides, small interfering RNA, and ribozymes to inhibit expression of the human steroid 5 alpha-reductase gene and thereby inhibit formation of dihydrotestosterone: skin diseases, hair loss, hirsuitism, and benign prostatic hyperplasia |
08/28/2008 | US20080207543 Modified pituitary gland development in offspring from expectant mother animals treated with growth hormone releasing hormone therapy |
08/28/2008 | US20080207542 Two double stranded nucleic acids, both with complimentary strands, a cationic lipid, a neutral lipid, and a polyethylene glycol-conjugate; for diagnosis, prevention and prophylaxis of HCV infection, liver failure, hepatocellular carcinoma, and cirrhosis |
08/28/2008 | US20080207541 Compositions and Methods For Optimizing Cleavage of Rna By Rnase H |
08/28/2008 | US20080207540 Use of LRH-1 response elements derived from the apolipoprotein A1 gene promoter, cells, vectors and genetic constructs to increase HDL levels; atherosclerosis |
08/28/2008 | US20080207539 Self-Processing Rna Expression Cassette |
08/28/2008 | US20080207520 Tumor-associated Peptides Binding Promiscuously to Human Leukocyte Antigen (HLA) Class II Molecules |
08/28/2008 | US20080207517 SELECTIVE INHIBITION OF NF-kappaB ACTIVIATION BY PEPTIDES DESIGNED TO DISRUPT NEMO OLIGOMERIZATION |
08/28/2008 | US20080207510 Modified vitamin k-dependent polypeptides |
08/28/2008 | US20080207506 Nucleic acid sequence coding Mammastatin; protein useful in diagnosis, therapy fo breast cancer ; antigrowth agents |
08/28/2008 | US20080207504 SECRETED FRIZZLED RELATED PROTEIN, sFRP, FRAGMENTS AND METHODS OF USE THEREOF |
08/28/2008 | US20080207487 Manufacturing process for the production of polypeptides expressed in insect cell-lines |
08/28/2008 | US20080207484 Polypeptides; hybrid nucleic acids; anticancer agents; central nervous system disorders |
08/28/2008 | US20080207459 Antibody diversity generation |
08/28/2008 | US20080207449 Polypeptides; antisense nucleic acids; gene expression vectors that have been inserted: transgenic plants; agriculture; diagnosis; screening; therapy |
08/28/2008 | US20080206873 Recombinant pre-integration complex (rPIC) for use as gene transfer tool in genetic engineering |
08/28/2008 | US20080206872 Nucleic acid integration in eukaryotes |
08/28/2008 | US20080206871 transfecting skeletal muscle cells in vivo with nucleic acids encoding the proteins by electroporation; results in production of the desired protein on the order of about 2-3 magnitudes more as compared to standard methods, allowing for various biological uses including purification and crystallization |
08/28/2008 | US20080206870 Pneumatic Capillary Gun for Ballistic Delivery of Microscopic Particles into Tissue |
08/28/2008 | US20080206869 modification of RNA or DNA molecules in order to add functions in terms of delivery and specificity to RNA interference or antisense technology |
08/28/2008 | US20080206848 channel for containing a sample comprising nucleic acids;a temperature controller having an area for controlling a temperature of the area through which the channel passes |
08/28/2008 | US20080206840 Cytotoxin-based biological containment |
08/28/2008 | US20080206838 Nanoscaling ordering of hybrid materials using genetically engineered mesoscale virus |
08/28/2008 | US20080206837 Stable adenoviral vectors and methods for propagation thereof |
08/28/2008 | US20080206836 Modified glucanase for use in textile and fabric treatment, detergents and papermaking |
08/28/2008 | US20080206835 Methods and Compositions Relating to Gene Silencing |
08/28/2008 | US20080206834 Recombinant organophosphorous acid anhydrase and methods of use |
08/28/2008 | US20080206832 selection and enrichment occurs in aqueous droplets formed in an emulsion that compartmentalize individual polynucleotides from the library or a plurality of polynucleotides that may include polynucleotides not derived from the library, transcription and translation reagents |
08/28/2008 | US20080206822 Method for Improving the Thermostability of Sucrose Phosphorylase (Sp) |
08/28/2008 | US20080206817 Vectors expressible in a host that is the rhaBAD promoter region of the L-rhamnose operon operably linked to a transcriptional unit that is:a) a nucleic acid sequence which is heterologouse to the host, andb) a prokaryotic signal sequence operably linked to the nucleic acid sequence |
08/28/2008 | US20080206816 Yeast host, transformant and method for producing heterologous proteins |
08/28/2008 | US20080206815 Polypeptides having cellulolytic enhancing activity and nucleic acids encoding same |
08/28/2008 | US20080206814 microorganism co-transformed with a recombinant expression vector containing E. coli outer membrane protein F (OmpF) and a recombinant expression vector containing a target protein to be secreted into cell culture broth, as well as a method of secreting and producing the target protein into cell culture |
08/28/2008 | US20080206813 Means and methods for regulating gene expression |
08/28/2008 | US20080206812 Generation of recombinant adeno- associated virus particles; generate nutrient broth, inoculate with genetically engineered cells, propagate cells and vector, release vector, harvest viral particles |
08/28/2008 | US20080206811 Process For Producing Polypeptide |
08/28/2008 | US20080206810 lacking all or a portion of the ST6GalNAcI signal domain; nucleic acids encoding such truncated polypeptides, as well as vectors, host cells, expression systems |
08/28/2008 | US20080206803 Metabolic genes and related methods and compositions |
08/28/2008 | US20080206788 Reagents and methods for the detection and quantification of vancomycin in biological fluids |
08/28/2008 | US20080206786 Trace amine receptor 1 of the african green monkey |
08/28/2008 | US20080206775 Method of Amplifying Nucleic Acids, Reagent Kit for Amplifying Nucleic Acids, Method of Detecting Single Nucleotide Polymorphism, and Reagent Kit for Detecting Single Nucleotide Polymorphism |
08/28/2008 | US20080206764 Flowcell system for single molecule detection |
08/28/2008 | US20080206763 Partitioning endogenous cellular transcription products and associated proteins for generating gene expression profile of cells |
08/28/2008 | US20080206759 Gene regulatory networks and methods of interdiction for controlling the differentiation state of a cell |
08/28/2008 | US20080206750 Novel fetal genes |
08/28/2008 | US20080206747 Methods, Kits and Compositions Pertaining to Combination Oligomers and Libraries for Their Preparation |
08/28/2008 | US20080206745 Nucleotide squences extraction solution; for use recovering preferential nucleic acids |
08/28/2008 | US20080206744 Functional Genomics and Gene Trapping in Haploid or Hypodiploid Cells |
08/28/2008 | US20080206284 E. coli heat-labile enterotoxin that binds to GM1 ganglioside receptors; allergic rhinitis |
08/28/2008 | US20080206283 Vaccine Against Sars |
08/28/2008 | US20080206282 Chimeric lyssavirus nucleic acids and polypeptides |
08/28/2008 | US20080206279 Human cells comprising sequence encoding early region-1 (E1) gene product of an adenovirus; cultured in suspension to very high densities under serum-free conditions |
08/28/2008 | US20080206269 stimulate the resuscitation of bacteria after true dormancy; cognate receptors, convertases, respective genes and inhibitors or mimetics |
08/28/2008 | US20080206267 Inactivation Of Genes Of The Mep Pathway |
08/28/2008 | US20080206266 Carbohydrate ligand that specifically binds to a leczyme; nucleic acid sequence encoding a nonclassical MHC class I heavy chain; ability to associate with a beta 2 microglobulin; major histocompatibility complex transplantation molecules |
08/28/2008 | US20080206255 Antibody cancer immunotherapy |
08/28/2008 | US20080206254 human monoclonal antibody of the IgG isotype; preventing and treating cardiovascular disorders; specifically binds to the A2 domain of FVIII |
08/28/2008 | US20080206252 Novel Polypeptides, and Nucleic Acids Encoding the Same |
08/28/2008 | US20080206250 Compositions and methods for the therapy and diagnosis of breast cancer |
08/28/2008 | US20080206249 comprise one or more breast tumor polypeptides, immunogenic portions thereof, polynucleotides that encode such polypeptides, antigen presenting cell that expresses such polypeptides, and T cells that are specific for cells expressing such polypeptides |
08/28/2008 | US20080206247 Glycoprotein VI fusion proteins |
08/28/2008 | US20080206245 Compositions and methods for the therapy and diagnosis of breast cancer |
08/28/2008 | US20080206244 Compositions and methods for the therapy and diagnosis of breast cancer |
08/28/2008 | US20080206238 Angiogenesis-Inhibiting Chimeric Protein and the Use |
08/28/2008 | US20080206234 Compositions and methods for the therapy and diagnosis of breast cancer |
08/28/2008 | US20080206233 Heavy Chain And Single Domain Antibodies |
08/28/2008 | US20080206230 Peptides Derived from Human Bplp Protein, Polynucleotides Coding for Said Peptides and Antibodies Directed Against Said Peptides |
08/28/2008 | US20080206229 Modified Antibodies Recognizing Receptor Trimers or Higher Multimers |
08/28/2008 | US20080206223 Treatment of pompe's disease |
08/28/2008 | US20080206220 Using NADH:flavin oxidoreductase as screening tool in identifying modulators for use in treatment of fungal infection |
08/28/2008 | US20080206218 T-helper cell peptide epitopes for use in targeting and treatment of cell prolferative disorders; immunotherapy |
08/28/2008 | US20080206217 Tumor-associated Peptides Binding Promiscuously to Human Leukocyte Antigen (HLA) Class II Molecules |
08/28/2008 | US20080206216 T-helper cell peptide epitopes for use in targeting and treatment of cell prolferative disorders; immunotherapy |
08/28/2008 | US20080206210 gene therapy by intrathymic administration; lentiviral vectors |
08/28/2008 | US20080206209 Myelinating or remyelinating dysmyelinated or demyelinated axons comprising: administering oligondendrocyte progenitor cells to dysmyelinated or demyelinated axons via intraventricular, intracallosal or intraparenchymal administration to brain, brain stem or spinal cord |
08/28/2008 | US20080206204 Using ionomycin and 6-dimethylaminopurine to induce parthenogenetic activation in non-inseminated human oocytes; treating diabetic, liver, blood, nervous system and cell prolierative disorders; regenerative medicine; tissue engineering |
08/28/2008 | US20080206199 Viral vector for target destruction of cancer cells |
08/28/2008 | US20080206198 Using epithelial sodium channel (ENaC) inhibitor to treat and prevent nervous system and lung disorders |
08/28/2008 | US20080206197 Metabolically activated recombinant viral vectors and methods for their preparation and use |
08/28/2008 | US20080206190 Glycosylated IL-7, Preparation And Uses |
08/28/2008 | US20080206154 Kill, inhibit growth or prevent the production of endogenously expressed toxin; treatment of sepsis |
08/28/2008 | US20080206144 Identification of a truncation polymorphism of the mdr1 gene that is linked to ivermectin sensitivity in subjects such as collie dogs; use in bioassay testing to see which drugs certain canines will have adverse reactions to; pharmacogenetics |
08/28/2008 | US20080206136 Binding Peptidomimetics and Uses of the Same |
08/28/2008 | US20080203502 Self-addressable self-assembling microelectronic systems and devices for molecular biological analysis and diagnostics |
08/28/2008 | US20080202541 Alteration of tobacco alkaloid content through modification of specific cytochrome P450 genes |
08/28/2008 | DE102007009347A1 Isolating nucleic acids comprises binding the nucleic acids adsorbtive to polar surfaces, washing the surfaces with substances solution after removing the binding mixture, which have an affinity to polar surfaces and to the nuclei acids |
08/28/2008 | CA2717664A1 Compositions and methods useful for site-directed recombination in plants |
08/28/2008 | CA2689046A1 Method of producing l-amino acid |
08/28/2008 | CA2680063A1 Compositions and methods for treating glycogen storage diseases |
08/28/2008 | CA2679602A1 Pyridine or pyrimidine derivative having excellent cell growth inhibition effect and excellent anti-tumor effect on cell strain having amplification of hgfr gene |
08/28/2008 | CA2679109A1 Highly efficient methods for reprogramming differentiated cells and for generating animals and embryonic stem cells from reprogrammed cells |
08/28/2008 | CA2678986A1 Erythropoietin fusion protein |
08/28/2008 | CA2678966A1 Chimeric newcastle disease virus vlps |